Nihon Kohden America Highlights EtCO2 Monitoring Solution for Post-Surgical Patients at ASA 2013
Safeguards At-Risk Post-Surgery Patients With Continuous EtC02 Monitoring
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 10/14/13 -- , a market leader in patient monitoring innovation, will be on hand at the Anesthesiology 2013 show, hosted by the American Society of Anesthesiologists (ASA), to provide demonstrations of its award-winning -- Early Detection and Notification System™. In keeping with the latest EtCO2 monitoring recommendations from the ASA, Prefense enables hospitals to monitor at-risk, post-surgical patients who are on opioid drips for End tidal CO2 (EtCO2).
EtCO2, the level of carbon dioxide released at the end of an exhaled breath, is an important parameter that indicates the condition of gas exchange in the lungs. Monitoring EtCO2 can help ensure medical safety during respiratory management, alerting medical staff to indications of respiratory compromise. Nihon Kohden America's Prefense system also enables medical personnel to monitor and track trends on vital statistics on a continuous basis during ambulation via a wireless transmitter. Prefense monitors four out of the seven key triggers (respiration rate from EtCO2 or impedance, oxygen saturation (SpO2), heart rate (HR), and blood pressure (NIBP)) that are early indicators of patient deterioration -- allowing for faster intervention by clinical staff.
Prefense makes an immediate clinical impact -- in the form of better patient outcomes -- and improves hospital economics due to reduced stays and fewer unplanned ICU and telemetry admissions. "Constant surveillance of key vital signs in post-surgical patients -- even while ambulating -- can make all the difference," said Mike Dashefsky, vice president, Nihon Kohden America. "Our fifth generation Prefense + EtCO2 enables end-to-end monitoring for better patient care. Our emphasis on is just one of the many examples of how Nihon Kohden America employs different thinking for better healthcare."
Nihon Kohden America will be showcasing its award-winning Prefense -- as well as its full line of complete perioperative solutions on the Anesthesiology 2013 show floor at the Moscone Center in San Francisco from October 12-16.
For more information, please visit .
The monitoring division of Nihon Kohden America is empowering hospitals to radically improve their quality and economics of care. Its singular focus is on patient monitoring. Through collaboration with hospitals, Nihon Kohden America helps solve today's healthcare challenges. This different mindset and business approach enables the company to deliver solutions that have an immediate clinical and financial impact. Find more information at .
Media Contact:
Stephanie Olsen
Lages & Associates
949-453-8080
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.10.2013 - 14:00 Uhr
Sprache: Deutsch
News-ID 305433
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Hardware
Diese Pressemitteilung wurde bisher 223 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Nihon Kohden America Highlights EtCO2 Monitoring Solution for Post-Surgical Patients at ASA 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
Nihon Kohden America (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
